1. Kalashnikova, L.A., Cerebrovascular disorders in antiphospholipid syndrome, Ann. Klin. Eksp. Nevrol., 2011, vol. 5, no. 1, pp. 39–43.
2. Suponeva, N.A., Piradov, M.A., Nikitin, S.S., et al., Pathogenetic and prognostic role of autoantibodies to gangliosides of the peripheral nerves in Guillain–Barre syndrome, Ann. Klin. Eksp. Nevrol., 2013, vol. 7, no. 1, pp. 4–11.
3. Alpa, M., Ferrero, B., Cavallo, R., et al., Anti-GM1 and anti-sulfatide antibodies in patients with systemic lupus erythematosus, Sjögren’s syndrome, mixed cryoglobulinemia and idiopathic systemic vasculitis, Clin. Exp. Rheumatol., 2007, vol. 25, pp. 556–562.
4. Álvarez-Cermeño, J.C., Muñoz-Negrete, F.J., Costa-Frossard, L., et al., Intrathecal lipid-specific oligoclonal IgM synthesis associates with retinal axonal loss in multiple sclerosis, J. Neurol. Sci., 2016, vol. 360, pp. 41–44.
5. Andersson, K., Buschard, K., Fredman, P., et al., Patients with insulindependent diabetes but not those with non-insulin-dependent diabetes have anti-sulfatide antibodies as determined with a new ELISA assay, Autoimmunity, 2002, vol. 35, pp. 463–468.